MediWound Ltd. Board of Directors

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in United States, Europe, and internationally. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx, which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; and MW005, which is in phase I/II for the treatment of low-risk basal cell carcinoma. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.

Mr. Barry J. Wolfenson

Mr. Barry J. Wolfenson

Executive Vice President of Strategy & Corporate Development

Dr. Liron Gal

Dr. Liron Gal

Executive Director of Manufacturing Science & Technology

Ms. Hani Luxenburg

Ms. Hani Luxenburg

Chief Financial Officer

Mr. Ofer Gonen B.Sc.

Mr. Ofer Gonen B.Sc.

Chief Executive Officer

Dr. Ety Klinger MBA, Ph.D.

Dr. Ety Klinger MBA, Ph.D.

Chief Research & Development Officer

Mr. Yaron Meyer Adv.

Mr. Yaron Meyer Adv.

Executive VP, General Counsel & Corporate Secretary

Dr. Shmulik Hess Ph.D.

Dr. Shmulik Hess Ph.D.

COO & Chief Commercial Officer

Leaving Board of Directors Review Your about to visit the following url Invalid URL

Loading...
Comments


Comment created.